Jump to main content
Jump to site search

Issue 11, 2019
Previous Article Next Article

S100A9-targeted tobacco mosaic virus nanoparticles exhibit high specificity toward atherosclerotic lesions in ApoE−/− mice

Author affiliations

Abstract

We integrate a biocompatible plant virus-based nanotechnology (tobacco mosaic virus, TMV) with S100A9-targeting peptides for its application in imaging and diagnosis of atherosclerosis. S100A9-targeted TMV nanoparticles exhibit remarkable specificity to S100A9 and targeting of atherosclerosis lesions in ApoE−/− mice.

Graphical abstract: S100A9-targeted tobacco mosaic virus nanoparticles exhibit high specificity toward atherosclerotic lesions in ApoE−/− mice

Back to tab navigation

Supplementary files

Publication details

The article was received on 28 Aug 2018, accepted on 04 Feb 2019 and first published on 13 Feb 2019


Article type: Communication
DOI: 10.1039/C8TB02276C
Citation: J. Mater. Chem. B, 2019,7, 1842-1846

  •   Request permissions

    S100A9-targeted tobacco mosaic virus nanoparticles exhibit high specificity toward atherosclerotic lesions in ApoE−/− mice

    J. Park, H. Gao, Y. Wang, H. Hu, D. I. Simon and N. F. Steinmetz, J. Mater. Chem. B, 2019, 7, 1842
    DOI: 10.1039/C8TB02276C

Search articles by author

Spotlight

Advertisements